Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.
2.
3.

Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.

Song L, Kong M, Ma Y, Ba M, Liu Z.

Brain Res. 2009 Jun 18;1276:171-9. doi: 10.1016/j.brainres.2009.04.028. Epub 2009 Apr 21.

PMID:
19393228
4.

Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.

Bové J, Marin C, Bonastre M, Tolosa E.

Synapse. 2002 Dec 15;46(4):251-7.

PMID:
12373740
5.

Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Bové J, Serrats J, Mengod G, Cortés R, Tolosa E, Marin C.

Exp Brain Res. 2005 Sep;165(3):362-74. Epub 2005 Jun 21.

PMID:
15968457
7.

Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA.

Eur J Neurosci. 2009 Sep;30(5):823-32. doi: 10.1111/j.1460-9568.2009.06877.x. Epub 2009 Aug 27.

PMID:
19712101
8.

Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.

Lane EL, Cheetham S, Jenner P.

J Neural Transm (Vienna). 2008;115(3):423-9. doi: 10.1007/s00702-007-0854-x. Epub 2008 Feb 4.

PMID:
18250952
9.

The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.

Marin C, Bové J, Serrats J, Cortés R, Mengod G, Tolosa E.

Exp Neurol. 2005 Jan;191(1):41-52.

PMID:
15589511
10.

ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.

Pavón N, Martín AB, Mendialdua A, Moratalla R.

Biol Psychiatry. 2006 Jan 1;59(1):64-74. Epub 2005 Sep 1.

PMID:
16139809
11.
12.

CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats.

Huang YX, Luo WF, Li D, Hu WD, Liu CF.

Brain Res. 2011 Feb 28;1376:113-21. doi: 10.1016/j.brainres.2010.12.070. Epub 2010 Dec 30.

PMID:
21195062
13.

AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.

Périer C, Marin C, Bonastre M, Tolosa E, Hirsch EC.

Eur J Neurosci. 2002 Dec;16(11):2236-40.

PMID:
12473092
14.
15.

Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA.

Eur J Neurosci. 2007 Jan;25(1):259-69.

PMID:
17241287
16.

Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Jiménez A, Bonastre M, Aguilar E, Marin C.

Psychopharmacology (Berl). 2009 Oct;206(2):233-42. doi: 10.1007/s00213-009-1600-x. Epub 2009 Jul 28.

PMID:
19636538
17.

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.

Marin C, Jiménez A, Bonastre M, Vila M, Agid Y, Hirsch EC, Tolosa E.

Synapse. 2001 Oct;42(1):40-7.

PMID:
11668589
18.

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.

Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM.

Exp Neurol. 2003 Oct;183(2):458-68.

PMID:
14552886
19.

The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.

Cox H, Togasaki DM, Chen L, Langston JW, Di Monte DA, Quik M.

Exp Neurol. 2007 May;205(1):101-7. Epub 2007 Feb 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk